DOD Amyotrophic Lateral Sclerosis, Clinical Outcomes and Biomarkers Award
The FY24 ALSRP Clinical Outcomes and Biomarkers Award aims to support the development and validation of clinical outcomes and biomarkers to enhance clinical trials for Amyotrophic Lateral Sclerosis (ALS). This includes projects focused on specific therapies, classes of therapeutics, or ALS subtypes like certain genetic mutations. Use of well-documented clinical resources is encouraged, includi…
Source
Award
Dates
Keywords
Supporting Links
Documents
Similar Opportunities
-
DoW Amyotrophic Lateral Sclerosis Research Program, Therapeutic Development Award
Dept. of the Army -- USAMRAA
-
Biomedical Research Projects
Motor Neurone Disease Association
-
DoW Amyotrophic Lateral Sclerosis Research Program, Therapeutic Idea Award
Dept. of the Army -- USAMRAA
-
Identify and Evaluate Potential Risk Factors for Amyotrophic Lateral Sclerosis (ALS)
Department of Health and Human Services ▸ Centers for Disease Control and Prevention - ERA
-
Clinical Trial Readiness for Rare Diseases, Disorders, and Syndromes (R21 Clinical Trial Not Allowed)
Department of Health and Human Services
Find tens of thousands more opportunities — free
Scout accounts are free. Sign up to browse the full funding database, unlock the solicitation links and documents for this opportunity, and see how well each one fits your organization.
-
Tens of thousands of funding opportunities
Search and filter every grant and solicitation in Scout — all free, no credit card required.
-
Instant Fit Analysis
Let our grant expert AI score how well this opportunity aligns with your organization, strengths, gaps, and how to improve your chances of winning funding.
-
Source links & full documents
Jump straight to the solicitation and download every attachment.
-
Save opportunities & track deadlines
Keep the opportunities that fit in one place and stay ahead of every due date.
Already have an account? Sign In
Trusted by 500+ Happy Customers